Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results

Q3 2024 net revenues of $285 million increased 8.5$17 million or $0.06 per diluted share, compared to net loss of$14 million or $0.05 per diluted share in Q3 2023 Q3 2024 Adjusted EBITDA(1) of$146 million increased 9.0%, compared to Q3 2023Q3 2024 Adjusted EPS(1) of $0.17 increased$0.01 per diluted share, compared to Q3 2023Reaffirming 2024 Net Revenue and Adjusted EBITDA outlook ranges CLEVELAND, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera ...